Motorola Solutions, Inc. (NYSE:MSI) Logo

Old National Bancorp increased its stake in Regeneron Pharmaceuticals (REGN) by 36.09% based on its latest 2018Q4 regulatory filing with the SEC. Old National Bancorp bought 2,510 shares as the company’s stock rose 19.30% with the market. The institutional investor held 9,465 shares of the health care company at the end of 2018Q4, valued at $3.54M, up from 6,955 at the end of the previous reported quarter. Old National Bancorp who had been investing in Regeneron Pharmaceuticals for a number of months, seems to be bullish on the $34.13 billion market cap company. The stock decreased 3.57% or $11.57 during the last trading session, reaching $312.6. About 1.12M shares traded or 47.49% up from the average. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has risen 34.82% since May 10, 2018 and is uptrending. It has outperformed by 30.45% the S&P500. Some Historical REGN News: 11/05/2018 – Bayer: Eylea Treats Visual Impairment From Macular Degeneration; 10/03/2018 – Regeneron and Sanofi Announce Plans to Make Praluent® (alirocumab) More Accessible and Affordable for Patients with the Greate; 16/05/2018 – Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic de; 03/04/2018 – REG-Sanofi: EMA to review Dupixent® (dupilumab) as potential treatment for inadequately controlled moderate-to-severe asthma; 10/03/2018 – NO PRALUENT SAFETY ISSUES ARISE IN MULTI-YEAR TRIAL – RESEARCHERS; 21/03/2018 – Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis (NASH); 30/04/2018 – Sanofi, Regeneron: Target Action Date for the FDA Decision Is October 28, 2018; 10/03/2018 – REGENERON PHARMACEUTICALS AND SANOFI SAY WILL OFFER LOWER NET PRICE FOR PRALUENT CHOLESTEROL DRUG FOR HIGHEST-RISK PATIENTS; 21/03/2018 – REGENERON & ALNYLAM: PACT TO DISCOVER NEW TREATMENTS FOR NASH; 03/04/2018 – EMA TO REVIEW DUPIXENT® (DUPILUMAB) AS POTENTIAL TREATMENT FOR INADEQUATELY CONTROLLED MODERATE-TO-SEVERE ASTHMA

Smith Asset Management Group Lp decreased its stake in Motorola Solutions Inc (MSI) by 7.15% based on its latest 2018Q4 regulatory filing with the SEC. Smith Asset Management Group Lp sold 11,170 shares as the company’s stock rose 7.52% with the market. The hedge fund held 145,049 shares of the technology company at the end of 2018Q4, valued at $16.69 million, down from 156,219 at the end of the previous reported quarter. Smith Asset Management Group Lp who had been investing in Motorola Solutions Inc for a number of months, seems to be less bullish one the $24.36B market cap company. The stock increased 1.76% or $2.56 during the last trading session, reaching $147.79. About 1.05M shares traded or 15.68% up from the average. Motorola Solutions, Inc. (NYSE:MSI) has risen 33.56% since May 10, 2018 and is uptrending. It has outperformed by 29.19% the S&P500. Some Historical MSI News: 28/03/2018 – Motorola Solutions Completes Acquisition Of Avigilon AVO.T; 03/05/2018 – Motorola Solutions 1Q EPS 69c; 16/04/2018 – TESARO: Regulatory Submission for TSR-042 for MSI-High Tumors Planned in 2H 2019; 03/05/2018 – MOTOROLA SOLUTIONS INC QTRLY SALES OF $1.5 BLN, UP 15 PERCENT FROM A YEAR AGO; 09/03/2018 – Tech Report: Rumor: MSI Titan laptop with a Core i7-8850H shows up at e-tailer; 07/03/2018 – ZAGG Announces Executive Leadership Transition; 09/05/2018 – MOTOROLA SOLUTIONS GETS TETRA RADIO TENDER IN GERMANY; 04/04/2018 – WiLAN Subsidiary Enters into License Agreement with MSI; 23/04/2018 – RadioResource: Motorola Wins $200M Contract in Australia; 23/04/2018 – MOTOROLA SOLUTIONS: PACT EXTENDED FOR 7 YRS, VALUED AT A$261M

Analysts await Motorola Solutions, Inc. (NYSE:MSI) to report earnings on August, 1. They expect $1.51 EPS, up 9.42% or $0.13 from last year’s $1.38 per share. MSI’s profit will be $248.85M for 24.47 P/E if the $1.51 EPS becomes a reality. After $1.16 actual EPS reported by Motorola Solutions, Inc. for the previous quarter, Wall Street now forecasts 30.17% EPS growth.

More notable recent Motorola Solutions, Inc. (NYSE:MSI) news were published by: Businesswire.com which released: “Motorola Solutions to Issue First-Quarter 2019 Earnings Results on May 2 – Business Wire” on April 18, 2019, also Businesswire.com with their article: “Motorola Solutions Announces Increase in Aggregate Purchase Price of Tender Offers for Certain of its Outstanding Debt – Business Wire” published on May 09, 2019, Seekingalpha.com published: “ITC gives partial win to Motorola, issues import ban on Hytera – Seeking Alpha” on November 16, 2018. More interesting news about Motorola Solutions, Inc. (NYSE:MSI) were released by: Benzinga.com and their article: “Earnings Scheduled For May 2, 2019 – Benzinga” published on May 02, 2019 as well as Businesswire.com‘s news article titled: “Motorola Solutions Again Recognized on Fortune’s List of ‘World’s Most Admired Companies’ – Business Wire” with publication date: January 22, 2019.

Since November 26, 2018, it had 0 insider buys, and 1 insider sale for $1.85 million activity.

Investors sentiment decreased to 0.91 in 2018 Q4. Its down 0.21, from 1.12 in 2018Q3. It dived, as 57 investors sold MSI shares while 180 reduced holdings. 71 funds opened positions while 144 raised stakes. 140.14 million shares or 4.43% more from 134.20 million shares in 2018Q3 were reported. Daiwa Sb Ltd stated it has 1,870 shares or 0.05% of all its holdings. State Street Corp, Massachusetts-based fund reported 7.63 million shares. Coatue Llc accumulated 665,020 shares. Lsv Asset Mgmt owns 679,110 shares. 467,391 were reported by Dimensional Fund Advsrs Lp. Mitsubishi Ufj & holds 0.17% of its portfolio in Motorola Solutions, Inc. (NYSE:MSI) for 344,789 shares. Royal Commercial Bank Of Canada has invested 0.02% of its portfolio in Motorola Solutions, Inc. (NYSE:MSI). Tompkins Finance reported 107 shares. Horizon Ltd Liability Co has invested 0.1% in Motorola Solutions, Inc. (NYSE:MSI). Chevy Chase Holdings stated it has 134,752 shares or 0.08% of all its holdings. The Georgia-based Synovus Fincl Corporation has invested 0.03% in Motorola Solutions, Inc. (NYSE:MSI). Bridges Invest Mgmt owns 10,396 shares. Interactive invested 0% of its portfolio in Motorola Solutions, Inc. (NYSE:MSI). Korea Invest holds 0.03% or 42,903 shares. Moreover, Zeke Advisors has 0.02% invested in Motorola Solutions, Inc. (NYSE:MSI).

Smith Asset Management Group Lp, which manages about $2.91 billion and $2.83 billion US Long portfolio, upped its stake in Biogen Inc (NASDAQ:BIIB) by 27,672 shares to 115,491 shares, valued at $34.87M in 2018Q4, according to the filing. It also increased its holding in Cadence Design Systems Inc (NASDAQ:CDNS) by 173,626 shares in the quarter, for a total of 1.17 million shares, and has risen its stake in Medifast Inc (NYSE:MED).

Since December 12, 2018, it had 0 insider buys, and 4 selling transactions for $55.44 million activity. 1,848 shares were sold by Fenimore Christopher R., worth $663,381. GOLDSTEIN JOSEPH L sold $734,310 worth of stock. Shares for $2,294 were sold by VAGELOS P ROY on Wednesday, December 12.

Old National Bancorp, which manages about $1.81 billion US Long portfolio, decreased its stake in Vanguard Bd Index Fd Inc (BSV) by 20,678 shares to 152,847 shares, valued at $12.01M in 2018Q4, according to the filing. It also reduced its holding in Bristol Myers Squibb Co (NYSE:BMY) by 8,649 shares in the quarter, leaving it with 93,373 shares, and cut its stake in Thermo Fisher Scientific Inc (NYSE:TMO).

More notable recent Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) news were published by: Nasdaq.com which released: “REGN Crosses Above Average Analyst Target – Nasdaq” on January 11, 2019, also Finance.Yahoo.com with their article: “Here’s the Bad News That Derailed Regeneron’s Stock – Yahoo Finance” published on May 08, 2019, Finance.Yahoo.com published: “Brief Commentary On Regeneron Pharmaceuticals, Inc.’s (NASDAQ:REGN) Fundamentals – Yahoo Finance” on May 06, 2019. More interesting news about Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) were released by: Nasdaq.com and their article: “Noteworthy Monday Option Activity: QCOM, PBYI, REGN – Nasdaq” published on February 25, 2019 as well as Seekingalpha.com‘s news article titled: “Regeneron Pharmaceuticals Q1 2019 Earnings Preview – Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) – Seeking Alpha” with publication date: May 06, 2019.

Investors sentiment decreased to 1.13 in 2018 Q4. Its down 0.01, from 1.14 in 2018Q3. It worsened, as 52 investors sold REGN shares while 165 reduced holdings. 72 funds opened positions while 174 raised stakes. 77.33 million shares or 9.82% more from 70.41 million shares in 2018Q3 were reported. Panagora Asset Mgmt Incorporated reported 0.01% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). The Ontario – Canada-based Sun Life Fincl has invested 0.02% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Piedmont stated it has 0.18% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Orbimed Advsrs Ltd Liability Company invested 1.53% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Parkside National Bank & Trust & Tru, a Missouri-based fund reported 45 shares. 877,965 are held by Clearbridge Invs Ltd. Churchill Management holds 0.03% or 1,959 shares. Aimz Inv Limited Com invested in 9,530 shares or 2.75% of the stock. Northern Corp reported 952,770 shares or 0.1% of all its holdings. Pictet And Cie (Europe) Sa has invested 0.06% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Lombard Odier Asset Management (Europe) Limited invested 0.03% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Loomis Sayles And Company LP invested in 3.16M shares or 2.79% of the stock. Moreover, Merian Global (Uk) has 0.24% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). The New York-based Cibc World Corporation has invested 0.09% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Halsey Ct has invested 1.33% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN).

Motorola Solutions, Inc. (NYSE:MSI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *